Product
L-Ascorbate
1 clinical trial
4 indications
Indication
Intermittent ClaudicationIndication
IntermittentIndication
Peripheral Artery DiseaseIndication
Peripheral Vascular DiseasesClinical trial
The Effects of ATLAS (Arginine Tetrahydrobiopterin L-Ascorbate) Therapy on Nitric Oxide Bioavailability and Pain-free Walking in Patients With Intermittent ClaudicationStatus: Recruiting, Estimated PCD: 2025-07-01